Want to see TRIB full AI Analyst Report?
Trinity Biotech (TRIB) Income Statement
Trinity Biotech Income Statement
Last quarter (Q4 2025), Trinity Biotech's total revenue was $11.06M, an increase of 46.04% from the same quarter last year. In Q4, Trinity Biotech's net income was $-17.46M. See Trinity Biotech’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Dec 22 | Mar 22 |
|---|---|---|---|---|---|
| $ 43.78M | $ 61.55M | $ 56.83M | $ 62.52M | $ 81.15M | |
| $ 16.89M | $ 21.44M | $ 19.45M | $ 22.05M | $ 33.45M | |
| $ 28.30M | $ 42.61M | $ 46.49M | $ 32.96M | $ 29.52M | |
| Depreciation and Amortization | $ 2.68M | $ 1.86M | $ 1.78M | $ 2.33M | $ 2.74M |
| $ -21.38M | $ -16.91M | $ -24.10M | $ -16.71M | $ 10.59M | |
| $ -11.42M | $ -21.16M | $ -27.05M | $ -15.27M | $ 3.94M | |
| $ -25.76M | $ -9.56M | $ -9.88M | $ -24.43M | $ -5.86M | |
| $ -37.18M | $ -30.73M | $ -36.93M | $ -43.78M | $ -1.92M | |
| $ -37.38M | $ -31.79M | $ -24.02M | $ -41.00M | $ 875.00K | |
| Per Share Metrics | |||||
| Basic EPS | $ -60.00 | $ -52.98 | $ -96.00 | $ -180.00 | $ 6.30 |
| Diluted EPS | $ -60.00 | $ -52.98 | $ -96.00 | $ -156.00 | $ 4.92 |
| Weighted Average Shares Outstanding | 619.20K | 598.65K | 255.15K | 224.90K | 139.35K |
| Weighted Average Shares Outstanding (Diluted) | 619.20K | 598.65K | 255.15K | 259.15K | 177.55K |
Currency in USD